Zamann Pharma Support

Zamann Pharma Support We from Zamann Pharma Support GmbH offer highest quality,
experience & consulting in the pharmaceutical area.

We are validation and support specialists of GxP processes and we provide comprehensive support for pharmaceutical companies.

Disruptions, stricter regulations, and growing complexity are redefining the pharmaceutical supply chain.Our new article...
04/06/2026

Disruptions, stricter regulations, and growing complexity are redefining the pharmaceutical supply chain.

Our new article looks at how pharma companies can combine strong governance, end-to-end GxP compliance, and real resilience to keep products safe, available, and compliant — from manufacturer to patient.

If you work in pharma supply chain, quality, or regulatory, this is a practical overview of what needs to change and where to start.

Read the full article here:
https://zamann-pharma.com/2026/03/12/supply-chain-in-pharma-industry-governance-compliance-and-resilience-in-year/

Are you confident that your Validation Master Plan (VMP) would stand up to an inspection today?Our new blog post explain...
02/06/2026

Are you confident that your Validation Master Plan (VMP) would stand up to an inspection today?

Our new blog post explains what inspectors expect to see in a modern VMP, which gaps they frequently uncover, and how you can prepare your documentation so it is clear, consistent, and fully aligned with your quality system.

If you work in pharma, biotech, or medical devices and deal with validation, quality, or CSV, this article will help you benchmark your current VMP and prioritize improvements.

Dive into the full article here: https://zamann-pharma.com/2026/03/02/validation-master-plan-vmp-inspection-expectations-in-year/

Signal detection is at the heart of pharmacovigilance – and a frequent focus in health authority inspections.Our latest ...
28/05/2026

Signal detection is at the heart of pharmacovigilance – and a frequent focus in health authority inspections.

Our latest blog looks at what inspectors are currently finding in signal detection systems: gaps in processes and documentation, unclear responsibilities, insufficient methods, and weaknesses in follow-up and CAPA.

We also share practical recommendations to help Marketing Authorisation Holders make their signal detection activities more robust, transparent, and inspection-ready.

Explore the full article here and see how your system compares:
https://zamann-pharma.com/2026/02/20/signal-detection-in-pharmacovigilance-in-year-inspection-findings/

How do you reliably define shelf life under today’s GMP and ICH expectations?Our latest article walks through key princi...
26/05/2026

How do you reliably define shelf life under today’s GMP and ICH expectations?

Our latest article walks through key principles of stability testing in a GMP environment – from designing your stability program to interpreting real-time and accelerated data, and managing OOS/OOT results.

If you work in QA/QC, regulatory, or product development, this guide will help you strengthen your stability strategy and stay inspection-ready.

Read the full article here: https://zamann-pharma.com/2026/02/19/shelf-life-determination-in-year-gmp-stability-focus/

Why are Good Manufacturing Practices (GMP) so strict today?Because they were shaped step by step by real incidents, regu...
21/05/2026

Why are Good Manufacturing Practices (GMP) so strict today?

Because they were shaped step by step by real incidents, regulatory findings, and years of intense inspection pressure.

Our latest blog post walks through the history of GMP – from early quality failures to the modern standards that pharma companies work with today. If you work in quality, production, or regulatory affairs, this background helps explain why auditors focus on certain topics and how GMP expectations keep evolving.

Read the full article here:
https://zamann-pharma.com/2026/02/18/good-manufacturing-practices-history-in-year-how-gmp-evolved-under-inspection-pressure/

GMP inspections are putting more and more emphasis on your vendors and supply chain.We’ve put together a clear, practica...
19/05/2026

GMP inspections are putting more and more emphasis on your vendors and supply chain.

We’ve put together a clear, practical Vendor Audit Checklist that helps you focus on the areas inspectors care about most – from quality systems and documentation to data integrity, supply reliability and risk management.

If you work in QA, supply chain or regulatory compliance, this guide can support your next vendor audit and help you stay inspection-ready.

Read the full article and download the checklist here:
https://zamann-pharma.com/2026/02/17/vendor-audit-checklist-in-year-gmp-inspection-focus/

GMP inspections are putting pharmaceutical documentation under even closer scrutiny.Our latest blog post explains what i...
14/05/2026

GMP inspections are putting pharmaceutical documentation under even closer scrutiny.

Our latest blog post explains what inspectors are focusing on now – from data integrity and ALCOA+ to consistent procedures, training records and the smart use of digital tools.

If you want to identify weak spots in your documentation and strengthen your quality system before the next inspection, this article is for you.

Read it here: https://zamann-pharma.com/2026/02/16/pharmaceutical-documentation-in-year-gmp-inspection-focus/

Adverse drug reactions (ADRs) are more than just a line item in a safety report – they are a critical part of how we pro...
12/05/2026

Adverse drug reactions (ADRs) are more than just a line item in a safety report – they are a critical part of how we protect patients throughout a medicine’s lifecycle.

Our new blog post walks you through how ADRs are identified, evaluated and managed from early clinical trials all the way to post-marketing surveillance, and why an integrated pharmacovigilance approach matters.

Get the full story and see how each stage of the pharmacovigilance lifecycle connects:
https://zamann-pharma.com/2026/02/13/adverse-drug-reactions-explained-across-the-pharmacovigilance-lifecycle-in-year/

Pharmacovigilance doesn’t stop once a medicine is approved.As a product moves from clinical trials into real‑world use, ...
07/05/2026

Pharmacovigilance doesn’t stop once a medicine is approved.

As a product moves from clinical trials into real‑world use, the way we collect, evaluate and act on safety data must adapt. Each phase of the lifecycle comes with specific pharmacovigilance tasks, regulatory expectations and opportunities to better protect patients.

In our new blog post, we break down the pharmacovigilance phases across the full product lifecycle and highlight what pharma and biotech companies should focus on at every step.

Explore the full article here: https://zamann-pharma.com/2026/02/12/pharmacovigilance-phases-explained-across-the-product-lifecycle-in-year/

GMP vs. ISO – do you prepare for these inspections in the same way?In practice, the expectations, focus points and even ...
05/05/2026

GMP vs. ISO – do you prepare for these inspections in the same way?

In practice, the expectations, focus points and even the way compliance is interpreted can be quite different. Our latest blog post walks you through the key differences, common inspection themes in 2026, and what this means for your quality system and daily operations.

If you work in pharma, biotech or any GxP-regulated environment, this overview can help you align your team and avoid surprises during audits.

Read the full article here:
https://zamann-pharma.com/2026/02/11/gmp-vs-iso-inspection-expectations-and-compliance-interpretation-in-year/

Adresse

SiedlerStr. 7
Lampertheim
68623

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Zamann Pharma Support erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Zamann Pharma Support senden:

Verknüpfungen

Teilen